Recent advancements in deep learning have significantly transformed the field of nuclear medicine, specifically in the detection and analysis of bone metastases via scintigraphy. By leveraging ...

Health-related quality of life after IMRT or IMRT+ HDR brachytherapy for intermediate or high-risk prostate cancer: Five-year results of a prospective trial. This is an ASCO Meeting Abstract from the ...

In a recent study published in Scientific Reports, a group of researchers investigated the differences in prostate magnetic resonance imaging (MRI) findings and clinical characteristics between ...

The second most common cancer among men is prostate cancer, affecting 1 in 8 men. Prostate cancer is treatable, in most cases ...

Circulating Tumor DNA Dynamics Fail to Predict Efficacy of Poly(ADP-ribose) Polymerase/VEGFR Inhibition in Patients With Heavily Pretreated Advanced Solid Tumors Patients with bone metastatic CRPC ...

The 2026 European Association of Urology (EAU) annual meeting featured a plenary prostate cancer session and a presentation by Dr. Jozefina Casuscelli discussing the optimal management of de-novo ...

Triple negative breast cancer (TNBC) is usually detected at later stages. Unfortunately, by this time the cancer has moved or metastasized to other tissues throughout the body. One of the most common ...

A new nano-sized drug carrier that finds bone tumors and releases treatment exactly where it's needed is here to improve the precision and comfort of cancer therapy. Designed by a team of researchers ...

Selvarangan Ponnazhagan, Ph.D., Endowed Professor in Experimental Cancer Therapeutics in the UAB Department of Pathology’s Division of Molecular and Cellular Pathology, has recently been awarded a ...

Cancer specialists have long known that anemia, caused by a lack of healthy red blood cells, can arise when cancer metastasizes to the bone, but it’s been unclear why. A research team led by Princeton ...